News
Pfizer: It Could Be A Bargain (NYSE:PFE)
In the last few years, I covered several pharmaceutical companies - including Gilead Sciences, Inc. (GILD), Novo Nordisk A/S (NVO)…
Southern Company Electric Utility Generates 3.7% Yield (NYSE:SO)
The Southern Company (NYSE:SO) is an electric utility conglomerate that offers power generation assets of many and varied types including…
Capitalizing On The Semiconductor Rebound: Why Lam Research Stock Is A Compelling Buy
I wrote my last article on Lam Research (NASDAQ:LRCX), titled Lam Research: An Opportune Moment To Add The Stock, on…
Ford Stock: Too Many Bad Developments Vs. The Few Bright Spots (NYSE:F)
Investment Thesis In my opinion, the risks and negative aspects of Ford (NYSE:F) outweigh the positive potential. After analyzing the…
VYM ETF: Still Hard To Justify An Entry Here (NYSEARCA:VYM)
November last year, I wrote an article on Vanguard High Dividend Yield ETF (NYSEARCA:VYM) making a case to avoid investing…
Cineverse Corp. (CNVS) Q4 2024 Earnings Call Transcript
Cineverse Corp. (NASDAQ:CNVS) Q4 2024 Earnings Conference Call July 1, 2024 4:30 PM ET Company Participants Gary Loffredo - Chief…
V.F. Corporation: Don’t Take Turnaround Success At Face Value (NYSE:VFC)
V.F. Corporation (NYSE:VFC) sells branded apparel, footwear, and accessories under a portfolio of brands. The brands include large, globally recognized…
Candel Therapeutics: Innovative Cancer Therapies, But Short Cash Runway (NASDAQ:CADL)
Candel Therapeutics, Inc. (NASDAQ:CADL) is a clinical-stage biopharmaceutical company developing biological immunotherapies for several types of cancer. CADL's treatments combine…